What is Exemplify BioPharma?
Exemplify BioPharma is a specialized entity focused on accelerating drug development through its integrated CMC laboratory and consulting services. The company provides critical expertise in Process Chemistry, Analytical Chemistry, and Formulation Development, guiding programs from late-stage lead optimization through to initial human trials. Leveraging over a century of combined leadership experience within the pharmaceutical and biotech sectors, Exemplify BioPharma partners with development teams to navigate pivotal decision-making milestones. Their services are designed for pharmaceutical and biotech firms aiming to optimize their drug development pipelines.
How much funding has Exemplify BioPharma raised?
Exemplify BioPharma has raised a total of $400K across 2 funding rounds:
Debt
$150K
Debt
$250K
Debt (2020): $150K with participation from PPP
Debt (2021): $250K led by PPP
What's next for Exemplify BioPharma?
The substantial late-stage funding indicates Exemplify BioPharma is poised for significant scaling and potentially further expansion of its service offerings or technological capabilities. This strategic investment will likely fuel the company's growth, enabling it to enhance its support for clients progressing through complex regulatory pathways and clinical development phases. The company's focus on critical CMC services positions it to capitalize on the ongoing demand for efficient and expert drug development support in the biopharmaceutical industry.
See full Exemplify BioPharma company page
